Slipped capital femoral epiphysis associated with vitamin D deficiency: a series of 15 cases

Bone Joint J. 2013 Jun;95-B(6):851-4. doi: 10.1302/0301-620X.95B6.30806.

Abstract

Slipped capital femoral epiphysis (SCFE) is uncommon in India and we routinely look for associated metabolic or endocrine abnormalities. In this study we investigated a possible association between vitamin D deficiency and SCFE. All children presenting with SCFE during the study period had their 25-hydroxyvitamin D levels measured as part of an overall metabolic, renal and endocrine status evaluation, which included measurement of body mass index (BMI). Vitamin D status was compared with age-, gender- and habitat-matched controls with acute trauma or sepsis presenting to our emergency department. A total of 15 children (12 boys and three girls) with a mean age of 13 years (sd 1.81; 10 to 16) presented for treatment for SCFE during a two-year period beginning in January 2010. Renal and thyroid function was within the normal range in all cases. The mean BMI was 24.9 kg/m(2) (17.0 to 33.8), which was significantly higher than that of the controls (p = 0.006). There was a statistically significant difference between the mean values of 25-hydroxyvitamin D in the children with SCFE and the controls (11.78 ng/ml (SD 5.4) versus 27.06 ng/ml (SD 5.53), respectively; p < 0.001). We concluded that, along with high BMI, there is a significant association of vitamin D deficiency and SCFE in India.

Keywords: 25 hydroxyvitamin D; SCFE; SUFE; Slipped upper femoral epiphysis; Vitamin D2; Vitamin D3.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Bone Density Conservation Agents / therapeutic use
  • Child
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • India / epidemiology
  • Male
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Slipped Capital Femoral Epiphyses / blood
  • Slipped Capital Femoral Epiphyses / epidemiology
  • Slipped Capital Femoral Epiphyses / etiology*
  • Vitamin D / analogs & derivatives
  • Vitamin D / blood*
  • Vitamin D / therapeutic use
  • Vitamin D Deficiency / complications*
  • Vitamin D Deficiency / drug therapy

Substances

  • Bone Density Conservation Agents
  • Vitamin D
  • 25-hydroxyvitamin D